Literature DB >> 19081406

Lipid levels in patients hospitalized with coronary artery disease: an analysis of 136,905 hospitalizations in Get With The Guidelines.

Amit Sachdeva1, Christopher P Cannon, Prakash C Deedwania, Kenneth A Labresh, Sidney C Smith, David Dai, Adrian Hernandez, Gregg C Fonarow.   

Abstract

BACKGROUND: Lipid levels among contemporary patients hospitalized with coronary artery disease (CAD) have not been well studied. This study aimed to analyze admission lipid levels in a broad contemporary population of patients hospitalized with CAD.
METHODS: The Get With The Guidelines database was analyzed for CAD hospitalizations from 2000 to 2006 with documented lipid levels in the first 24 hours of admission. Patients were divided into low-density lipoprotein cholesterol (LDL), high-density lipoprotein cholesterol (HDL), and triglyceride categories. Factors associated with LDL and HDL levels were assessed along with temporal trends.
RESULTS: Of 231,986 hospitalizations from 541 hospitals, admission lipid levels were documented in 136,905 (59.0%). Mean lipid levels were LDL 104.9 +/- 39.8, HDL 39.7 +/- 13.2, and triglyceride 161 +/- 128 mg/dL. Low-density lipoprotein cholesterol <70 mg/dL was observed in 17.6% and ideal levels (LDL <70 with HDL > or =60 mg/dL) in only 1.4%. High-density lipoprotein cholesterol was <40 mg/dL in 54.6% of patients. Before admission, only 28,944 (21.1%) patients were receiving lipid-lowering medications. Predictors for higher LDL included female gender, no diabetes, history of hyperlipidemia, no prior lipid-lowering medications, and presenting with acute coronary syndrome. Both LDL and HDL levels declined over time (P < .0001).
CONCLUSIONS: In a large cohort of patients hospitalized with CAD, almost half have admission LDL levels <100 mg/dL. More than half the patients have admission HDL levels <40 mg/dL, whereas <10% have HDL > or =60 mg/dL. These findings may provide further support for recent guideline revisions with even lower LDL goals and for developing effective treatments to raise HDL.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19081406     DOI: 10.1016/j.ahj.2008.08.010

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  78 in total

1.  Using apolipoprotein B to manage dyslipidemic patients: time for a change?

Authors:  Charles R Harper; Terry A Jacobson
Journal:  Mayo Clin Proc       Date:  2010-05       Impact factor: 7.616

2.  Evaluation of the association between sleep apnea and polyunsaturated fatty acids profiles in patients after percutaneous coronary intervention.

Authors:  Keisuke Nakabayashi; Kentaro Jujo; Katsumi Saito; Toshiaki Oka; Nobuhisa Hagiwara
Journal:  Heart Vessels       Date:  2017-06-19       Impact factor: 2.037

Review 3.  Potential contributions of intimal and plaque hypoxia to atherosclerosis.

Authors:  Guo-Hua Fong
Journal:  Curr Atheroscler Rep       Date:  2015-06       Impact factor: 5.113

Review 4.  Transforming growth factor-β and atherosclerosis: interwoven atherogenic and atheroprotective aspects.

Authors:  Ian Toma; Timothy A McCaffrey
Journal:  Cell Tissue Res       Date:  2011-05-31       Impact factor: 5.249

5.  Facts and ideas from anywhere.

Authors: 
Journal:  Proc (Bayl Univ Med Cent)       Date:  2015-01

6.  Variations in the eicosapentaenoic acid-arachidonic acid ratio associated with age in acute myocardial infarction patients undergoing primary percutaneous coronary intervention.

Authors:  Keisuke Nakabayashi; Kentaro Jujo; Yuho Furuki; Issei Ishida; Hiroshi Ando; Minoru Shimizu; Nobuhisa Hagiwara; Katsumi Saito
Journal:  Heart Vessels       Date:  2018-11-14       Impact factor: 2.037

7.  Coronary risk assessment among intermediate risk patients using a clinical and biomarker based algorithm developed and validated in two population cohorts.

Authors:  D S Cross; C A McCarty; E Hytopoulos; M Beggs; N Nolan; D S Harrington; T Hastie; R Tibshirani; R P Tracy; B M Psaty; R McClelland; P S Tsao; T Quertermous
Journal:  Curr Med Res Opin       Date:  2012-11       Impact factor: 2.580

8.  Nanomedicines for Endothelial Disorders.

Authors:  Bomy Lee Chung; Michael J Toth; Nazila Kamaly; Yoshitaka J Sei; Jacob Becraft; Willem J M Mulder; Zahi A Fayad; Omid C Farokhzad; YongTae Kim; Robert Langer
Journal:  Nano Today       Date:  2015-12-01       Impact factor: 20.722

9.  Digital thermal monitoring (DTM) of vascular reactivity closely correlates with Doppler flow velocity.

Authors:  Gary L McQuilkin; David Panthagani; Ralph W Metcalfe; Haider Hassan; Albert A Yen; Morteza Naghavi; Craig J Hartley
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2009

10.  2009 World Congress on the Insulin Resistance Syndrome: cardiovascular disease concepts.

Authors:  Zachary T Bloomgarden
Journal:  Diabetes Care       Date:  2010-07       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.